GDRX — what changed in the latest 10-Q
A section-by-section comparison of GDRX's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-05 vs the prior 10-Q · 2026-05-06
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +70 | −39 | ~21 | 172 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 2 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 13 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 2 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | 0 | 0 | ~1 | 3 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-05
quarter. Monthly Active Consumers from acquired companies are included beginning from the acquisition date.
Companion which launched its monthly and annual plans in May and July 2026, respectively. References to
second quarter of 2026, a new subscription offering that provides consumers access to free and low-cost generic
medications, affordable online care visits, and savings on routine healthcare services.
material impact on our business to date. In May 2026, an expansion of TrumpRx was announced to include more than 600
Text removed vs the prior filing · source: 10-Q · 2026-05-06
quarter. Effective January 1, 2025, Monthly Active Consumers from acquired companies are included
of TrumpRx on our business, offerings, or results of operations remains uncertain and could be material. With the
introduction of these federal initiatives, including the renewed focus on Most-Favored-Nation pricing, the market is shifting
decisively toward greater transparency and direct-to-consumer access. For us, this evolution is both an opportunity and a
and pharmacy economics, including the growing relevance of self-pay and direct-to-consumer distribution models, we are
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice